Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

This study has been completed.
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00521430
First received: August 24, 2007
Last updated: March 25, 2013
Last verified: October 2007